Director's Dealing • Feb 25, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
News Details
Directors’ Dealings | 24 February 2025 13:16
aap Implantate AG: Nino Buckow, Purchase of shares through the exercise of conversion rights
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
24.02.2025 / 13:15 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
| Title: | |
| First name: | Nino |
| Last name(s): | Buckow |
2. Reason for the notification
a) Position / status
| Person closely associated with: | |
| Title: | |
| First name: | Agnieszka |
| Last name(s): | Mierzejewska |
| Position: | Member of the managing body |
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
aap Implantate AG
b) LEI
39120001TRQTQ01LPP57
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
| Type: | Financial instrument linked to a share or a debt instrument |
| ISIN: | DE000A351ZH9 |
b) Nature of the transaction
Purchase of shares through the exercise of conversion rights
c) Price(s) and volume(s)
| Price(s) | Volume(s) |
| 1.03 EUR | 20000.54 EUR |
d) Aggregated information
| Price | Aggregated volume |
| 1.03 EUR | 20000.54 EUR |
e) Date of the transaction
21/02/2025; UTC+1
f) Place of the transaction
Outside a trading venue
24.02.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | aap Implantate AG |
| Lorenzweg 5 | |
| 12099 Berlin | |
| Germany | |
| Internet: | www.aap.de |
| End of News | EQS News Service |
97137 24.02.2025 CET/CEST
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.